4 Biotech companies backed by Wellington Management, including Tubulis, Atsena Therapeutics, Avalyn Pharma — with the co-investors on each cap table.
Wellington Management — Biotech accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.7B. The median disclosed raise is $200M, and the largest is Tubulis at $575M, ahead of Ollin Biosciences ($330M) and Boundless Bio ($256M).
The names that recur most often on these portfolio cap tables are Wellington Management (8 companies), Versant Ventures (3 companies), ARCH Venture Partners (3 companies), Nextech Invest (3 companies), Atlas Venture (3 companies), Janus Henderson Investors (3 companies). By latest disclosed round, the market skews Series A (3), Series C (3), Series B (2).
Wellington Management Company LLP profile · All research reports